Labcode 3A- HIV neutralization testing with Chronically infected PM1 HIV-1_Hela Fusion Assay
- Mauro Malnati
DOI Publisher
Harvard DataverseAbstract
HIV neutralization Protocol utilizing Chronically infected PM1 HIV-1/Hela Fusion Assa
HIV neutralization Protocol utilizing Chronically infected PM1 HIV-1/Hela Fusion Assa
This document contains a published paper with a detailed protocol on a high-throughput, high-content...
This document contains a detailed protocol of the plaque reduction assays using human cell lines eng...
<p>% Neutralization obtained with 1∶20 plasma dilution, ≥80% reduction in virus titer is highlighted...
This document describes the isolation of Peripheral Blood Mononuclear Cells (PBMCs) from buffycoat, ...
This protocol includes a detailed protocol of HIV neutralizaion assay based on pseudovirus produced ...
This protocol describes a HIV neutralisation assay in the microtiter plate format, that measures red...
This protocol describes a HIV neutralisation assay based on single cycle virus infectivity assay in ...
This document describes the isolation of Peripheral Blood Mononuclear Cells (PBMCs) from buffycoat, ...
This protocol describes a HIV neutralisation assay based on reduction in virus infectivity following...
This protocol, similarly to the protocol of Labcode 2, describes a pseudovirus assay that measures n...
This protocol, similarly to the protocol of Labcode 2, describes a pseudovirus assay that measures n...
This document contains a detailed protocol of a recombinant virus assay, developed to measure virus-...
This document contained a protocol on HIV neutralization utilizing recombinant viruses in HEK-293T c...
This document contains a protocol for HIV neutralization utilizing Pseudovirus in U87.CD4.CCR5 cell
This protocol describes the preparation and titration of pseudovirus (PV) and the detection of neutr...
This document contains a published paper with a detailed protocol on a high-throughput, high-content...
This document contains a detailed protocol of the plaque reduction assays using human cell lines eng...
<p>% Neutralization obtained with 1∶20 plasma dilution, ≥80% reduction in virus titer is highlighted...
This document describes the isolation of Peripheral Blood Mononuclear Cells (PBMCs) from buffycoat, ...
This protocol includes a detailed protocol of HIV neutralizaion assay based on pseudovirus produced ...
This protocol describes a HIV neutralisation assay in the microtiter plate format, that measures red...
This protocol describes a HIV neutralisation assay based on single cycle virus infectivity assay in ...
This document describes the isolation of Peripheral Blood Mononuclear Cells (PBMCs) from buffycoat, ...
This protocol describes a HIV neutralisation assay based on reduction in virus infectivity following...
This protocol, similarly to the protocol of Labcode 2, describes a pseudovirus assay that measures n...
This protocol, similarly to the protocol of Labcode 2, describes a pseudovirus assay that measures n...
This document contains a detailed protocol of a recombinant virus assay, developed to measure virus-...
This document contained a protocol on HIV neutralization utilizing recombinant viruses in HEK-293T c...
This document contains a protocol for HIV neutralization utilizing Pseudovirus in U87.CD4.CCR5 cell
This protocol describes the preparation and titration of pseudovirus (PV) and the detection of neutr...
This document contains a published paper with a detailed protocol on a high-throughput, high-content...
This document contains a detailed protocol of the plaque reduction assays using human cell lines eng...
<p>% Neutralization obtained with 1∶20 plasma dilution, ≥80% reduction in virus titer is highlighted...
Add to ORKG